150 related articles for article (PubMed ID: 7678740)
1. Metabolism and mode of selective inhibition of human immunodeficiency virus replication by 3'-azido-2',3'-dideoxy-5-iodouridine and 3'-azido-2',3'-dideoxy-5-bromouridine.
August EM; Qian HY; Birks EM; Thombre UA; Lin TS; Prusoff WH
Biochem Pharmacol; 1993 Jan; 45(1):223-30. PubMed ID: 7678740
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia virus.
Lin TS; Shen ZY; August EM; Brankovan V; Yang H; Ghazzouli I; Prusoff WH
J Med Chem; 1989 Aug; 32(8):1891-5. PubMed ID: 2754712
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 4'-azidothymidine. A compound with potent and selective activity against the human immunodeficiency virus.
Chen MS; Suttmann RT; Wu JC; Prisbe EJ
J Biol Chem; 1992 Jan; 267(1):257-60. PubMed ID: 1730594
[TBL] [Abstract][Full Text] [Related]
5. Effect of 3'-deoxythymidin-2'-ene (d4T) on nucleoside metabolism in H9 cells.
Marongiu ME; August EM; Prusoff WH
Biochem Pharmacol; 1990 May; 39(10):1523-8. PubMed ID: 2159760
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate.
Eriksson BF; Chu CK; Schinazi RF
Antimicrob Agents Chemother; 1989 Oct; 33(10):1729-34. PubMed ID: 2480079
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine.
Cheng YC; Goz B; Neenan JP; Ward DC; Prusoff WH
J Virol; 1975 May; 15(5):1284-5. PubMed ID: 167186
[TBL] [Abstract][Full Text] [Related]
9. Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta.
Chen MS; Suttmann RT; Papp E; Cannon PD; McRoberts MJ; Bach C; Copeland WC; Wang TS
Biochemistry; 1993 Jun; 32(23):6002-10. PubMed ID: 7685186
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of poly(ADP-ribose)polymerase activity by nucleoside analogs of thymidine.
Pivazyan AD; Birks EM; Wood TG; Lin TS; Prusoff WH
Biochem Pharmacol; 1992 Sep; 44(5):947-53. PubMed ID: 1530662
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of some 5'-amino-2',5'-dideoxy-5-iodouridine derivatives and their antiviral properties against herpes simplex virus.
Markham AF; Newton CR; Porter RA; Sim IS
Antiviral Res; 1982 Dec; 2(6):319-30. PubMed ID: 6299187
[TBL] [Abstract][Full Text] [Related]
12. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
Sastry JK; Nehete PN; Khan S; Nowak BJ; Plunkett W; Arlinghaus RB; Farquhar D
Mol Pharmacol; 1992 Mar; 41(3):441-5. PubMed ID: 1372082
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells.
Allaudeen HS; Chen MS; Lee JJ; De Clercq E; Prusoff WH
J Biol Chem; 1982 Jan; 257(2):603-6. PubMed ID: 6274855
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidine.
Schinazi RF; Chu CK; Eriksson BF; Sommadossi JP; Doshi KJ; Boudinot FD; Oswald B; McClure HM
Ann N Y Acad Sci; 1990; 616():385-97. PubMed ID: 1706574
[TBL] [Abstract][Full Text] [Related]
15. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
Fischer PH; Murphy DG; Kawahara R
Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
[TBL] [Abstract][Full Text] [Related]
16. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
Cheng YC; Dutschman G; De Clercq E; Jones AS; Rahim SG; Verhelst G; Walker RT
Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
[No Abstract] [Full Text] [Related]
17. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
De Clercq E; Bernaerts R; Merta A; Rosenwirth B
Mol Pharmacol; 1990 May; 37(5):658-64. PubMed ID: 2160059
[TBL] [Abstract][Full Text] [Related]
18. 3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus.
Olsen JC; Furman P; Fyfe JA; Swanstrom R
J Virol; 1987 Sep; 61(9):2800-6. PubMed ID: 2441079
[TBL] [Abstract][Full Text] [Related]
19. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
Kit S; Ichimura H; De Clercq E
Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
[TBL] [Abstract][Full Text] [Related]
20. 3'-C-branched 2'-deoxy-5-methyluridines: synthesis, enzyme inhibition, and antiviral properties.
Fedorov II; Kazmina EM; Novicov NA; Gurskaya GV; Bochkarev AV; Jasko MV; Victorova LS; Kukhanova MK; Balzarini J; De Clercq E
J Med Chem; 1992 Nov; 35(24):4567-75. PubMed ID: 1281882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
